The Regulatory Digest. Regulatory changes, explained in plain language.
Every month, a clear summary of what changed in regenerative medicine regulation: FDA and FTC news, state-by-state rule changes, enforcement updates, and what it means for your practice. Date-stamped and sourced, never hype.
Join the launch list
Pricing will be announced at launch. Join now for first access and early pricing.
No spam, ever Unsubscribe anytime Educational use only
Enforcement update and product status
Two new warning letters issued to clinics making unapproved claims. No new approvals for the product categories covered in Genademy coursework.
Three states updated their scope rules
Arizona clarified supervision requirements. Florida updated documentation standards. Utah proposed a change for comment.
Advertising enforcement patterns
New guidance on how claims in clinic marketing are evaluated, with examples of language regulators flag.
What this means for your clinic
Three quick checks for your consent forms, website copy, and supplier documentation this month.
What you get each month
FDA and FTC news
Warning letters, guidance, enforcement actions, and product status changes, summarized without the legalese.
State-by-state changes
Which states passed laws, updated scope rules, or opened comment periods, and what each change requires.
Date-stamped analysis
Every item carries its source and date, so you know exactly how current your picture of the landscape is.
Practice implications
Each issue closes with quick checks for your consent forms, website copy, and supplier documentation.